New drug nemolizumab tested for rare skin disease
Disease control
Completed
This phase 2 trial tested the drug nemolizumab in 6 people with systemic sclerosis, a rare disease that causes skin thickening. The goal was to see if the drug could improve skin symptoms and to check its safety. Participants received injections of nemolizumab, and doctors measur…
Phase: PHASE2 • Sponsor: Maruho Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC